益普索健康服务报告2025

A 30-Country IpsosGlobal Advisor SurveyOctober 2025 Summary Low awarenessof GLP-1s globally, buthigh in the most advanced economies Mental health is seen as the top healthproblem People much more likely to think thelevel of care they get is good than bad Across 30 countries only 36% has heard aboutGLP-1 drugs such as Ozempic andWegovy.However, this rises to 74% in the US. Despitemuch discussion about the effectiveness ofthe drugs, only around one in eight think therewill be fewer obese people in their country in10 years’ time. 45% onaverage across 30countries seemental health as a problem in their nation. Itranks ahead of cancer (41%) and obesity (25%)as the biggest health problems. Perception ofmental health as an issue rose rapidly duringthe pandemic and the proportion that see it asa problem has increased by 18 points since2018. Four in ten (43%) rate the quality of thehealthcare they have access to in theircountry as good. Only 22% rate the care theyreceive as poor. Malaysia and the Netherlands are the mostlikely to feel their healthcare system is good.Britain and Canada have experienced markedfalls in their ratings in recent years. Of those that heard of the drugs, people aremost likely to have been made aware of themfrom social media.45% heard about GLP-1sfrom social media, while only 19%knew aboutthem from a medical professional. As worry about mental health has risen, worryabout stress has risen too. 31% see it as aproblem. At the same time 59% say in the pastyear there have been points when they were sostressed they could not cope. While many European countries are morelikely to rate their healthcare as good ratherthan poor, many think it will get worse in thefuture. We explore how the new narrative aroundGLP-1s is not being set by pharma companiesor traditional healthcare companies, butinfluencers and telehealth. Additionally, 76% say mental and physicalhealth are equally important, but 38% thinktheir healthcare system treat them as such. One in two (51%) in France, 39% in Germanyand the Netherlands expect quality to godown in the coming years. At a glance Perceived biggesthealthcare problems: 45% on average across 30countries say mental healthis the biggest healthconcern. This is up from27% in 2018. Cancer,stress,obesity, and drug abusefollow as concerns. across 30 countries haveheard of GLP-1 drugs, suchas Ozempic,Wegovy,Zepbound,RybelsusorMounjaro. Awareness ishighest in the US (74%). 43% 28% (on average) rate thequality of healthcare theyreceive as good. Thisranges from 75% inMalaysia feeling theirhealthcare is good, to only12% in Hungary. on average think the quality oftheir healthcare will improve overthe comingyears, down from 34%in 2018. Twenty-one per centthink the quality will get worse. At a glance: Brazil Perceived biggesthealthcare problems: 52% ofColombianssaymentalhealthis the biggest healthconcern. Up from 18% in2018. inBrazilbelieve the qualityof healthcare will improve.Down from 61% in 2018. Access to treatment/long waitingtimes 34% 80% think the quality of theirhealthcare is either goodor very good. Up from18%in 2018. say many people in my countrycannot afford good healthcare. Upfrom 74% in 2018. CONTENTS 4 3 2 1 Obesity and GLP-1s Mental Health The biggest healthproblems Healthcaresatisfaction 7 5 6 Vaccines and Trust The challengesfacing healthcareservices Methodology Obesity and GLP-1s Have you heard about GLP-1drugs such as Ozempic,Wegovy,Zepbound,RybelsusorMounjaro? Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. How did you hear about GLP-1drugs? 30-Country Average Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. How did you hear about GLP-1drugs?US Average Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. Up until the age of 50 people are mostlikely to have heard about GLP-1s fromsocial media, while people over 50 aremore to be aware of them from traditionalmedia. How did you hear about GLP-1 drugs?30-Country Average Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. In your opinion do you thinkthere will be more or lessobese people in your countryin 10 years time? Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. Top health issues Thinking generally, which ofthe following, if any, do yousee as the biggest healthproblems facing people inyour country today? 30-Country Average Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 2025. Thinking generally, which ofthe following, if any, do yousee as the biggest healthproblems facing people inyour country today? 30-Country Average, 2018–2025 Top five challenges (+COVID) Base:23,172 online adults under the age of75 across 30 countries, interviewed 25 July–8 August 20